FEATURED ARTICLES
Examine how integrating electronic Patient Reported Outcomes (ePROs) in early clinical research not only enhances understanding of the drug's effects but also amplifies its market value.
-
Assessing The 3Cs: Does Your Organization Have The Foundation For Clinical Trial Success?
In part one of this series on exploring the importance of culture, communication, and collaboration, the authors discuss the makings of a strong company foundation and offer an assessment plan meant to reveal strengths and weaknesses in those three areas.
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.
-
For Veteran PI, Research Requires Motivation, Dedication, And CRO Support
Principal investigator Dr. Luke Twelves discusses how he remained motivated to continue conducting trials and shares insights into what he thinks will inspire others to do the same.